Stock Markets July 9, 2026 07:26 PM

OpenAI Product Chief Fidji Simo Moves to Part-Time Advisory Role Amid Health-Related Leave

Simo cites a severe exacerbation of a chronic illness; departure comes as OpenAI prepares for an IPO and pursues a new consumer 'superapp'

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
MSFT

Fidji Simo, OpenAI's head of products and business and the company's second-ranking executive, announced she is stepping back from full-time duties to take on a part-time advisory role due to complications from a chronic illness. Her medical leave followed a severe exacerbation three months ago, and recovery is expected to be more prolonged and complex than initially anticipated. The change occurs as OpenAI readies for a potential initial public offering and continues efforts to refresh growth after ChatGPT expansion stalled.

OpenAI Product Chief Fidji Simo Moves to Part-Time Advisory Role Amid Health-Related Leave
MSFT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Fidji Simo is stepping down from her full-time role as head of products and business at OpenAI and will move into a part-time advisory position due to complications from a chronic illness; she began an extended medical leave after a severe exacerbation three months ago.
  • Simo oversaw OpenAI's consumer products and led efforts to develop a consolidated consumer experience, described internally as a 'superapp' that the company unveiled the same day as her announcement.
  • The change comes as OpenAI prepares for a potential initial public offering this year or next, while addressing slowing ChatGPT growth and undertaking financial restructuring to reduce cash burn - developments that affect the AI and broader technology sectors.

Fidji Simo, who served as head of products and business at OpenAI and was widely regarded as the company's second-in-command after CEO Sam Altman, said on Thursday that she will relinquish full-time responsibilities and transition into a part-time advisory capacity because of health complications.

In a social media statement, Simo explained that three months ago she experienced a "severe exacerbation of a chronic illness," which required an extended medical leave. She said the trajectory of her recovery has changed and is now expected to take longer and be more complex than first thought, prompting the move to a reduced role.

At OpenAI, Simo led product and business efforts for the company's consumer-facing portfolio. Her remit included oversight of consumer offerings and she had a central role in steering development toward a consolidated consumer experience - an initiative described within the company as work on a "superapp," which OpenAI unveiled earlier on the same day as her announcement.

Simo joined OpenAI following senior executive stints at other technology companies, where she held leadership roles including chief executive of an online grocery platform and a senior role at a major social media company. Within OpenAI, she was responsible for a range of consumer-facing product decisions and strategy.

The timing of Simo's shift to part-time advisory status coincides with a critical juncture for OpenAI. The company is preparing for a possible initial public offering, targeted either this year or next, while simultaneously addressing a slowdown in expansion of ChatGPT user growth that analysts and the company have noted this year.

OpenAI is also reported to be revising internal financial management and taking steps to cut cash burn as it moves toward a public listing. The company has acknowledged competitive pressure from rival AI firms, including Anthropic, and has been working to accelerate product development and regain momentum in consumer growth.

Simo's departure from day-to-day duties reduces the company's operational bench strength in product leadership at a moment when it is both refining its consumer strategy and preparing the business for public markets. OpenAI confirmed the role change in Simo's disclosure but has not provided additional detail on succession or how her advisory role will be structured.


Context and implications

The change in Simo's status is a personnel development that intersects with OpenAI's broader strategic priorities: completing product work on a consolidated consumer offering, confronting slowing user growth for core products, and tightening financial discipline ahead of an IPO.

Risks

  • Leadership gap risk - Simo's move to a part-time advisory role reduces full-time product leadership capacity at OpenAI during a critical period of product consolidation and IPO preparation, which could affect product execution and consumer strategy - impacts the AI and technology sectors.
  • Health-driven uncertainty - The trajectory and duration of Simo's recovery are uncertain; this personal health situation has prompted an organizational change whose long-term effects on timelines and initiatives are unclear - impacts company operations and investor sentiment.
  • Market and growth risk - OpenAI is confronting slowed growth for ChatGPT and increased competition from rivals such as Anthropic while overhauling finances to cut cash burn, creating uncertainty around near-term growth and profitability as it approaches a public market debut - impacts public markets and the AI industry.

More from Stock Markets

Samsung’s Lee Plans U.S. Meeting With Nvidia’s Huang as Firms Coordinate on Chips and AI Jul 9, 2026 OpenAI’s Applications Chief Fidji Simo Moves From Full-Time Role to Part-Time Advisor Following Medical Leave Jul 9, 2026 Federal Police Raid Targets Executive Linked to Banco Master Communication Effort Jul 9, 2026 CCC Intelligent Solutions Engages Morgan Stanley to Explore Strategic Options, Including Possible Sale Jul 9, 2026 AWS launches Loom for AWS to standardize secure AI agent lifecycles Jul 9, 2026